Synthesis and Antiproliferative Activity Evaluation of Aryl(Hetaryl)Cyclopentenone Analogs of Combretastatin A-4
- Authors: Shirinyan V.Z.1, Markosyan A.I.2, Baryshnikova M.A.3, Yaminova L.V.4, L’vov A.G.1, Gabrielyan S.A.2
- 
							Affiliations: 
							- N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences
- Scientific and Technological Center of Organic and Pharmaceutical Chemistry, National Academy of Sciences of Armenia
- N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
- D. I. Mendeleev University of Chemical Technology of Russia
 
- Issue: Vol 51, No 10 (2018)
- Pages: 867-872
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244834
- DOI: https://doi.org/10.1007/s11094-018-1706-8
- ID: 244834
Cite item
Abstract
A series of previously unreported di- and triaryl(hetaryl)cyclopentenone derivatives were prepared using a convenient synthetic method and screened preliminarily for antitumor activity in four human cell lines, i.e., T-cell leukemia (Jurkat), lung adenocarcinoma (A-549), colon cancer (HCT-116), and breast adenocarcinoma (MCF-7). The most cytotoxic of the tested compounds was 2-(3,4,5-trimethoxyphenyl)-3-(4-methoxyphenyl) cyclopent-2-en-1-one. However, it was inactive against lymphocytic leukemia P388 in mice despite its cytotoxicity in in vitro tests.
About the authors
V. Z. Shirinyan
N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences
							Author for correspondence.
							Email: shir@ioc.ac.ru
				                					                																			                												                	Russian Federation, 							47 Leninskii Prosp, Moscow, 119991						
A. I. Markosyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry, National Academy of Sciences of Armenia
														Email: shir@ioc.ac.ru
				                					                																			                												                	Armenia, 							26 Azatutyan Pr., 0014, Yerevan, 375014						
M. A. Baryshnikova
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
														Email: shir@ioc.ac.ru
				                					                																			                												                	Russian Federation, 							23 Kashirskoe Shosse, Moscow, 115478						
L. V. Yaminova
D. I. Mendeleev University of Chemical Technology of Russia
														Email: shir@ioc.ac.ru
				                					                																			                												                	Russian Federation, 							9 Miusskaya Pl., Moscow, 125047						
A. G. L’vov
N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences
														Email: shir@ioc.ac.ru
				                					                																			                												                	Russian Federation, 							47 Leninskii Prosp, Moscow, 119991						
S. A. Gabrielyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry, National Academy of Sciences of Armenia
														Email: shir@ioc.ac.ru
				                					                																			                												                	Armenia, 							26 Azatutyan Pr., 0014, Yerevan, 375014						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					